#bivalent — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #bivalent, aggregated by home.social.
-
A novel, bivalent RSV vaccine provides lasting protection against respiratory syncytial viral disease over two rather than only one season. #RSV #bivalent #vaccine #renoir #pfizer #universityrochester
https://www.instagram.com/drhowardsmithreports/reel/DH9MacqsZKC/ -
A novel, bivalent RSV vaccine provides lasting protection against respiratory syncytial viral disease over two rather than only one season. #RSV #bivalent #vaccine #renoir #pfizer #universityrochester
https://www.instagram.com/drhowardsmithreports/reel/DH9MacqsZKC/ -
A novel, bivalent RSV vaccine provides lasting protection against respiratory syncytial viral disease over two rather than only one season. #RSV #bivalent #vaccine #renoir #pfizer #universityrochester
https://www.instagram.com/drhowardsmithreports/reel/DH9MacqsZKC/ -
A novel, bivalent RSV vaccine provides lasting protection against respiratory syncytial viral disease over two rather than only one season. #RSV #bivalent #vaccine #renoir #pfizer #universityrochester
https://www.instagram.com/drhowardsmithreports/reel/DH9MacqsZKC/ -
A novel, bivalent RSV vaccine provides lasting protection against respiratory syncytial viral disease over two rather than only one season. #RSV #bivalent #vaccine #renoir #pfizer #universityrochester
https://www.instagram.com/drhowardsmithreports/reel/DH9MacqsZKC/ -
[Articles] #Effectiveness of BNT162b2 BA.4/5 #bivalent #mRNA #vaccine against a range of #COVID19 outcomes in a large health system in the #USA: a test-negative case–control study https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00306-5/fulltext?rss=yes
-
[Articles] #Effectiveness of BNT162b2 BA.4/5 #bivalent #mRNA #vaccine against a range of #COVID19 outcomes in a large health system in the #USA: a test-negative case–control study https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00306-5/fulltext?rss=yes
-
[Articles] #Effectiveness of BNT162b2 BA.4/5 #bivalent #mRNA #vaccine against a range of #COVID19 outcomes in a large health system in the #USA: a test-negative case–control study https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00306-5/fulltext?rss=yes
-
[Articles] #Effectiveness of BNT162b2 BA.4/5 #bivalent #mRNA #vaccine against a range of #COVID19 outcomes in a large health system in the #USA: a test-negative case–control study https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00306-5/fulltext?rss=yes
-
[Articles] #Effectiveness of BNT162b2 BA.4/5 #bivalent #mRNA #vaccine against a range of #COVID19 outcomes in a large health system in the #USA: a test-negative case–control study https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00306-5/fulltext?rss=yes
-
-
-
-
-
-
[Articles] #Efficacy of a #bivalent (D614 B.1.351) #SARS-CoV-2 recombinant protein #vaccine with #AS03 #adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00263-1/fulltext?rss=yes #research #covid19
-
[Articles] #Efficacy of a #bivalent (D614 B.1.351) #SARS-CoV-2 recombinant protein #vaccine with #AS03 #adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00263-1/fulltext?rss=yes #research #covid19
-
[Articles] #Efficacy of a #bivalent (D614 B.1.351) #SARS-CoV-2 recombinant protein #vaccine with #AS03 #adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00263-1/fulltext?rss=yes #research #covid19
-
[Pre-print] Faraone et al, 2023: Serum from people who received BA.4/5 #bivalent vaccines, many of whom had recent #COVID19 infections, still showed a 10x drop in neutralization for EG.5.1 (vs. BA.4/5). EG.5.1 is antigenically distant from XBB.
https://www.reddit.com/r/COVIDZero/comments/16fb9rp/preprint_faraone_et_al_2023_serum_from/ -
[Pre-print] Faraone et al, 2023: Serum from people who received BA.4/5 #bivalent vaccines, many of whom had recent #COVID19 infections, still showed a 10x drop in neutralization for EG.5.1 (vs. BA.4/5). EG.5.1 is antigenically distant from XBB.
https://www.reddit.com/r/COVIDZero/comments/16fb9rp/preprint_faraone_et_al_2023_serum_from/ -
[Pre-print] Faraone et al, 2023: Serum from people who received BA.4/5 #bivalent vaccines, many of whom had recent #COVID19 infections, still showed a 10x drop in neutralization for EG.5.1 (vs. BA.4/5). EG.5.1 is antigenically distant from XBB.
https://www.reddit.com/r/COVIDZero/comments/16fb9rp/preprint_faraone_et_al_2023_serum_from/ -
[Pre-print] Faraone et al, 2023: Serum from people who received BA.4/5 #bivalent vaccines, many of whom had recent #COVID19 infections, still showed a 10x drop in neutralization for EG.5.1 (vs. BA.4/5). EG.5.1 is antigenically distant from XBB.
https://www.reddit.com/r/COVIDZero/comments/16fb9rp/preprint_faraone_et_al_2023_serum_from/ -
[Pre-print] Faraone et al, 2023: Serum from people who received BA.4/5 #bivalent vaccines, many of whom had recent #COVID19 infections, still showed a 10x drop in neutralization for EG.5.1 (vs. BA.4/5). EG.5.1 is antigenically distant from XBB.
https://www.reddit.com/r/COVIDZero/comments/16fb9rp/preprint_faraone_et_al_2023_serum_from/ -
Effectiveness of #bivalent #mRNA #vaccines against medically attended symptomatic #SARS-CoV-2 #infection and #COVID19-related #hospital admission among SARS-CoV-2-naive and previously infected individuals: a retrospective cohort study, Lancet Infect Dis.: https://doi.org/10.1016/S1473-3099(23)00373-0 #research #medicine #pandemic
-
Effectiveness of #bivalent #mRNA #vaccines against medically attended symptomatic #SARS-CoV-2 #infection and #COVID19-related #hospital admission among SARS-CoV-2-naive and previously infected individuals: a retrospective cohort study, Lancet Infect Dis.: https://doi.org/10.1016/S1473-3099(23)00373-0 #research #medicine #pandemic
-
Effectiveness of #bivalent #mRNA #vaccines against medically attended symptomatic #SARS-CoV-2 #infection and #COVID19-related #hospital admission among SARS-CoV-2-naive and previously infected individuals: a retrospective cohort study, Lancet Infect Dis.: https://doi.org/10.1016/S1473-3099(23)00373-0 #research #medicine #pandemic
-
[Correspondence] #Bivalent #COVID19 #mRNA #vaccine against #omicron #subvariants in immunocompromised patients https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00357-2/fulltext?rss=yes #immunology #publichealth #epidemiology
-
[Correspondence] #Bivalent #COVID19 #mRNA #vaccine against #omicron #subvariants in immunocompromised patients https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00357-2/fulltext?rss=yes #immunology #publichealth #epidemiology
-
[Correspondence] #Bivalent #COVID19 #mRNA #vaccine against #omicron #subvariants in immunocompromised patients https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00357-2/fulltext?rss=yes #immunology #publichealth #epidemiology
-
@RedFaster Very nice, Sergei, you must think that you have now adroitly managed to twist my twisting of your words, that tried to twist my original post, to suit your disinformation agenda. I do remember blocking you, Sergei, the first time round, but you've just jumped servers, to take another kick at the can, which I am now calling you out for, publicly. See how that works? Get your shingles shot(s) Sergei! Oh, and your #COVID #bivalent booster. #VaccinesWork #GetVaccinated
-
@RedFaster Very nice, Sergei, you must think that you have now adroitly managed to twist my twisting of your words, that tried to twist my original post, to suit your disinformation agenda. I do remember blocking you, Sergei, the first time round, but you've just jumped servers, to take another kick at the can, which I am now calling you out for, publicly. See how that works? Get your shingles shot(s) Sergei! Oh, and your #COVID #bivalent booster. #VaccinesWork #GetVaccinated
-
Our fall COVID boosters will likely be a monovalent XBB formula - Enlarge / Vials with COVID-19 vaccine labels showing logos of pharmaceu... - https://arstechnica.com/?p=1948365 #annualvaccine #fallvaccine #monovalent #sars-cov-2 #bivalent #covid-19 #seasonal #science #omicron #xbb.1.5 #health #cdc #fda #flu #xbb
-
Our fall COVID boosters will likely be a monovalent XBB formula - Enlarge / Vials with COVID-19 vaccine labels showing logos of pharmaceu... - https://arstechnica.com/?p=1948365 #annualvaccine #fallvaccine #monovalent #sars-cov-2 #bivalent #covid-19 #seasonal #science #omicron #xbb.1.5 #health #cdc #fda #flu #xbb
-
Our fall COVID boosters will likely be a monovalent XBB formula - Enlarge / Vials with COVID-19 vaccine labels showing logos of pharmaceu... - https://arstechnica.com/?p=1948365 #annualvaccine #fallvaccine #monovalent #sars-cov-2 #bivalent #covid-19 #seasonal #science #omicron #xbb.1.5 #health #cdc #fda #flu #xbb
-
Our fall COVID boosters will likely be a monovalent XBB formula - Enlarge / Vials with COVID-19 vaccine labels showing logos of pharmaceu... - https://arstechnica.com/?p=1948365 #annualvaccine #fallvaccine #monovalent #sars-cov-2 #bivalent #covid-19 #seasonal #science #omicron #xbb.1.5 #health #cdc #fda #flu #xbb
-
Our fall COVID boosters will likely be a monovalent XBB formula - Enlarge / Vials with COVID-19 vaccine labels showing logos of pharmaceu... - https://arstechnica.com/?p=1948365 #annualvaccine #fallvaccine #monovalent #sars-cov-2 #bivalent #covid-19 #seasonal #science #omicron #xbb.1.5 #health #cdc #fda #flu #xbb
-
Ars Technica: Our fall COVID boosters will likely be a monovalent XBB formula https://arstechnica.com/?p=1948365 #Tech #arstechnica #IT #Technology #annualvaccine #fallvaccine #monovalent #SARS-CoV-2 #bivalent #COVID-19 #seasonal #Science #omicron #XBB.1.5 #Health #CDC #fda #flu #XBB
-
Ars Technica: Our fall COVID boosters will likely be a monovalent XBB formula https://arstechnica.com/?p=1948365 #Tech #arstechnica #IT #Technology #annualvaccine #fallvaccine #monovalent #SARS-CoV-2 #bivalent #COVID-19 #seasonal #Science #omicron #XBB.1.5 #Health #CDC #fda #flu #XBB
-
Ars Technica: Our fall COVID boosters will likely be a monovalent XBB formula https://arstechnica.com/?p=1948365 #Tech #arstechnica #IT #Technology #annualvaccine #fallvaccine #monovalent #SARS-CoV-2 #bivalent #COVID-19 #seasonal #Science #omicron #XBB.1.5 #Health #CDC #fda #flu #XBB
-
Ars Technica: Our fall COVID boosters will likely be a monovalent XBB formula https://arstechnica.com/?p=1948365 #Tech #arstechnica #IT #Technology #annualvaccine #fallvaccine #monovalent #SARS-CoV-2 #bivalent #COVID-19 #seasonal #Science #omicron #XBB.1.5 #Health #CDC #fda #flu #XBB
-
"ATAGI has reviewed the available evidence and advises that for people aged 12 years or older, a bivalent COVID-19 vaccine is now preferred over original (ancestral) vaccines for primary vaccination"
#COVID19Aus #bivalent #COVIDvaccine
https://www.health.gov.au/news/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older -
"ATAGI has reviewed the available evidence and advises that for people aged 12 years or older, a bivalent COVID-19 vaccine is now preferred over original (ancestral) vaccines for primary vaccination"
#COVID19Aus #bivalent #COVIDvaccine
https://www.health.gov.au/news/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older -
"ATAGI has reviewed the available evidence and advises that for people aged 12 years or older, a bivalent COVID-19 vaccine is now preferred over original (ancestral) vaccines for primary vaccination"
#COVID19Aus #bivalent #COVIDvaccine
https://www.health.gov.au/news/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older -
"ATAGI has reviewed the available evidence and advises that for people aged 12 years or older, a bivalent COVID-19 vaccine is now preferred over original (ancestral) vaccines for primary vaccination"
#COVID19Aus #bivalent #COVIDvaccine
https://www.health.gov.au/news/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older -
"ATAGI has reviewed the available evidence and advises that for people aged 12 years or older, a bivalent COVID-19 vaccine is now preferred over original (ancestral) vaccines for primary vaccination"
#COVID19Aus #bivalent #COVIDvaccine
https://www.health.gov.au/news/atagi-advice-on-the-preferential-use-of-bivalent-covid-19-vaccines-for-primary-vaccination-of-people-aged-12-years-or-older -
CW: COVID-19 Vaccination
@rchusid The thing that irritates me is I’m not freaking allowed to get my second #bivalent #booster. I’m not over 65 or “ #immunocompromised.” I do have several comorbid risk factors, but apparently that’s not bad enough to have my protection renewed after 7 months. Or my child after 6 months.
We are ready and eager, but being booster blocked. It’s irritating, especially since we’re back at school and office, and hearing about people getting sick.
-
CW: COVID-19 Vaccination
@rchusid The thing that irritates me is I’m not freaking allowed to get my second #bivalent #booster. I’m not over 65 or “ #immunocompromised.” I do have several comorbid risk factors, but apparently that’s not bad enough to have my protection renewed after 7 months. Or my child after 6 months.
We are ready and eager, but being booster blocked. It’s irritating, especially since we’re back at school and office, and hearing about people getting sick.
-
CW: COVID-19 Vaccination
@rchusid The thing that irritates me is I’m not freaking allowed to get my second #bivalent #booster. I’m not over 65 or “ #immunocompromised.” I do have several comorbid risk factors, but apparently that’s not bad enough to have my protection renewed after 7 months. Or my child after 6 months.
We are ready and eager, but being booster blocked. It’s irritating, especially since we’re back at school and office, and hearing about people getting sick.
-
CW: COVID-19 Vaccination
@rchusid The thing that irritates me is I’m not freaking allowed to get my second #bivalent #booster. I’m not over 65 or “ #immunocompromised.” I do have several comorbid risk factors, but apparently that’s not bad enough to have my protection renewed after 7 months. Or my child after 6 months.
We are ready and eager, but being booster blocked. It’s irritating, especially since we’re back at school and office, and hearing about people getting sick.
-
CW: COVID-19 Vaccination
@rchusid The thing that irritates me is I’m not freaking allowed to get my second #bivalent #booster. I’m not over 65 or “ #immunocompromised.” I do have several comorbid risk factors, but apparently that’s not bad enough to have my protection renewed after 7 months. Or my child after 6 months.
We are ready and eager, but being booster blocked. It’s irritating, especially since we’re back at school and office, and hearing about people getting sick.